POST Facilitation for Post-Traumatic Stress Disorder
(POST-RCT Trial)
Trial Summary
What is the purpose of this trial?
We propose to study the effects of Physician Orders for Scope of Treatment (POST) Facilitation in a randomized controlled trial in a population of community dwelling older adults who qualify for POLST facilitation, including those with normal cognition and those with Alzheimer's Disease and Related Disorders.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Home Safety Evaluation, POST Facilitation for PTSD?
The research suggests that psychological interventions, like cognitive processing therapy, are effective for PTSD, with significant symptom reductions reported. Additionally, early interventions targeting the mechanisms of PTSD can be beneficial, as indicated by studies on web-based cognitive-affective remediation.12345
Is POST Facilitation for PTSD safe for humans?
How is POST Facilitation treatment different from other PTSD treatments?
POST Facilitation is unique because it focuses on psychophysiological interventions, which address the body's physical responses to stress, unlike traditional therapies that primarily focus on psychological aspects. This approach may include techniques like self-hypnosis and clinical hypnosis, which are not commonly used in standard PTSD treatments.311121314
Research Team
Alexia M Torke, MD
Principal Investigator
Regenstrief Institute, Indiana University
Eligibility Criteria
This trial is for community-dwelling older adults aged 65 or above with certain serious health conditions like metastatic cancer, heart failure, kidney disease, COPD, or advanced Alzheimer's. They must have a high risk of mortality within a year and either be able to make decisions themselves or have a surrogate decision maker. Those already in hospice care or with an existing POST form are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive POST Facilitation or Home Safety Evaluation
Follow-up
Participants are monitored for outcomes such as decision conflict, psychological well-being, and POST form completion
Outcome Assessment
Assessment of primary and secondary outcomes including discordance between treatment preferences and treatment received
Treatment Details
Interventions
- Home Safety Evaluation
- POST Facilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Aging (NIA)
Collaborator
Regenstrief Institute, Inc.
Collaborator
Indiana University Health
Collaborator
Eskenazi Health
Collaborator
Respecting Choices
Collaborator